Characteristic Liver Manifestations of Glycogen Storage Disease Type Ⅰa: A Retrospective Study of 82 Cases
-
摘要:
目的 探讨糖原累积症(glycogen storage disease, GSD)Ⅰa型的肝脏受累特点。 方法 回顾性分析2006年1月至2013年12月在北京协和医院住院治疗的82例基因确诊为GSD Ⅰa型患儿的临床资料及肝脏影像学结果, 并总结其肝脏受累特点。 结果 82例GSDⅠa型患儿中, 男55例, 女27例; 出现症状平均年龄为(1.2±0.9)岁, 其中42例(54.9%)以发现肝脏肿大为首要原因就诊。13.4%(11/82)患儿出现肝脏腺瘤, 腺瘤出现年龄平均(15.7±3.0)岁(12~23岁); 63.6%(7/11)为多发腺瘤, 36.4%(4/11)为单发腺瘤。单发肝脏腺瘤均位于肝脏右叶, 多发腺瘤均表现为左叶及右叶均有分布。1例患儿行肝动脉栓塞治疗, 1例合并腺瘤癌变。 结论 GSD Ⅰa型是小儿较常见的导致肝脏肿大的遗传代谢病之一, 至青春期左右易发生肝脏腺瘤, 部分癌变。定期随诊腹部超声意义重大。对年长儿不明原因的多发肝脏腺瘤要注意鉴别GSD Ⅰa型。 Abstract:Objective To summarize the characteristic liver manifestations of glycogen storage disease type Ⅰa(GSD Ⅰa). Methods We retrospectively analyzed the clinical data and liver image results of 82 genetically diagnosed GSD Ⅰa patients hospitalized in Peking Union Medical College Hospital between January 2006 and December 2013, and summarized the characteristics of liver involvement of these patients. Results The 82 patients included 55 boys and 27 girls. Their symptoms developed at the mean age of (1.2±0.9) years. Forty-two patients (54.9%) visited doctors because of hepatomegaly. Eleven(13.4%) had hepatic adenomas, which appeared at the age of (15.7±3.0) years (12-23 years). Among them, 63.6% (7/11) had multiple adenomas, and the other(36.4%, 4/11) had single ones. The single adenomas were all located in the right lobe of the liver, and the multiple adenomas all involved both left and right lobes of the liver. One child received hepatic arterial embolization. One child had adenoma with canceration. Conclusions GSD Ⅰa is one of the most common hereditary metabolic diseases, which can cause hepatomegaly in chidren and liver adenoma in adolescents, some developing into cancer. Regular follow-up with abdominal ultrasound examination is important. In differential diagnosis of multiple liver adenomas of unknown origin in older children, attention should be paid to the possibility of GSD Ⅰa. -
Key words:
- glycogen storage disease Ⅰa /
- liver involvement /
- adenoma
-
[1] Chou JY, Mansfield BC. Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ⅰa glycogen storage disease[J]. Hum Mutat, 2008, 29:921-930. doi: 10.1002/humu.20772 [2] Carvalho PM, Silva NJ, Dias PG, et al. Glcogen Storage Disease type 1a-a secondary cause for hyperlipidemia:report of five cases[J]. J Diabetes Metab Disord, 2013, 12:25. doi: 10.1186/2251-6581-12-25 [3] Chen YT, Cornblath M, Sidbury JB. Cornstarch therapy in type Ⅰ glycogen-storage disease[J]. N Engl J Med, 1984, 310:171-175. doi: 10.1056/NEJM198401193100306 [4] Chou JY, Jun HS, Mansfield BC. Glycogen storage disease type Ⅰ and G6Pase-β deficiency:etiology and therapy[J]. Nat Rev Endocrinol, 2010, 6:676-688. doi: 10.1038/nrendo.2010.189 [5] Mason HH, Andersen DH. Glycogen disease of the liver (von Gierke's disease) with hepatomata; case report with metabolic studies[J]. Pediatrics, 1955, 16:785-800. http://europepmc.org/abstract/MED/13273118 [6] Rake, JP, Visser G, Labrune P, et al. Glycogen storage disease type Ⅰ:diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease type Ⅰ (ESGSD I)[J]. Eur J Pediatr, 2002, 161:S20-S34. doi: 10.1007/s00431-002-0999-4 [7] Wang DQ, Fiske LM, Carreras CT, et al. Natural history of hepatocellular adenoma formation in glycogen storage disease type Ⅰ[J]. J Pediatr, 2011, 159:442-446. doi: 10.1016/j.jpeds.2011.02.031 [8] Di Rocco M, Calevo MG, Taro M, et al. Hepatocellular adenoma and metabolic balance in patients with type Ⅰa glycogen storage disease[J]. Mol Genet Metab, 2008, 93:398-402. doi: 10.1016/j.ymgme.2007.10.134 [9] Kishnani PS, Chuang TP, Bali D, et al. Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ⅰa glycogen storage disease[J]. Hum Mol Genet, 2009, 18:4781-4190. doi: 10.1093/hmg/ddp441 [10] Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma:new classification and relationship with HCC[J]. Hepatology, 2006, 43:515-524. doi: 10.1002/hep.21068 [11] Weinstein DA, Wolfsdorf JI. Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease[J]. Eur J Pediatr, 2002, 161:S35-S39. doi: 10.1007/s00431-002-1000-2 [12] Lee YM, Jun HS, Pan CJ, et al. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ⅰa by gene therapy[J]. Hepatology, 2012, 56:1719-1729. doi: 10.1002/hep.25717 [13] Janice YC, Hyun SJ, Brian CM. Glycogen storage disease type Ⅰ and G6Pase-beta deficiency:etiology and therapy[J]. Nat Rev Endocrinol, 2010, 6:676-688. doi: 10.1038/nrendo.2010.189
点击查看大图
计量
- 文章访问数: 120
- HTML全文浏览量: 70
- PDF下载量: 3
- 被引次数: 0